Antihypoxidotic and nootropic drugs: proof of their encephalotropic and pharmacodynamic properties by quantitative EEG investigations.
D000328:Adult; D000367:Age Factors; D000368:Aged; D001549:Benzamides / Q000008:administration & dosage / Q000494:pharmacology; D001921:Brain / Q000187:drug effects*; D002936:Cinnarizine / Q000494:pharmacology; D002986:Clinical Trials as Topic; D004088:Dihydroergotoxine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004338:Drug Combinations / Q000494:pharmacology; D004569:Electroencephalography; D005260:Female; D006592:Hexobendine / Q000008:administration & dosage / Q000494:pharmacology; D006801:Humans; D007556:Isoxsuprine / Q000494:pharmacology; D000077287:Levetiracetam; D008297:Male; D008875:Middle Aged; D009530:Nicergoline / Q000494:pharmacology; D010889:Piracetam / Q000031:analogs & derivatives / Q000494:pharmacology; D011619:Psychotropic Drugs / Q000494:pharmacology*; D013806:Theophylline / Q000031:analogs & derivatives / Q000494:pharmacology; D013997:Time Factors
D001549:Benzamides; D004338:Drug Combinations; D011619:Psychotropic Drugs; D004088:Dihydroergotoxine; D002936:Cinnarizine; D000077287:Levetiracetam; C001453:Instenon; D006592:Hexobendine; D013806:Theophylline; D009530:Nicergoline; C100268:ethamivan; D007556:Isoxsuprine; D010889:Piracetam